Friday, July 24, 2009

Recruitment Completed in Arzerra (Ofatumumab) Phase II Study in Relapsed DLBCL http://bit.ly/uZlJX
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)